New Market Research Report: Digestive Remedies in Canada

From: Fast Market Research, Inc.
Published: Tue Dec 29 2015


Digestive remedies, including diarrhoeal remedies, indigestion and heartburn remedies, laxatives and motion sickness remedies, increased by 3% in current value terms in 2015, to reach C$422 million. Contributing to growth was the growing older population, as older people typically experience more digestive health disorders, according to WebMD, due to a lack of physical activity, a lack of fluid intake and physiological changes. Based on Euromonitor International analysis, the population aged 65 years and over grew by 4% in 2015, and is likely to continue to expand at this rate annually throughout the forecast period. This far exceeds the national average of 1% population growth annually. Other factors contributing to the growing demand for digestive remedies were busier lifestyles and poor diet, with high demand for unhealthy processed foods and beverages.

Competitive Landscape

McNeil Consumer Healthcare remained the largest brand owner in digestive remedies in 2015 with a 22% value share, with brands such as Imodium, Pepcid and Lactaid, each of which is the leading brand in its respective category: diarrhoeal remedies, H2 blockers and digestive enzymes respectively. Church & Dwight (Gravol and Diovol) followed with a 10% value share. Other major brand owners include GlaxoSmithKline Consumer Healthcare Canada (Tums, Eno, Maalox, Gas-X, Ex-Lax, Prodiem, The Procter & Gamble Co (Metamucil), Purdue-Frederick (Senokot), Prestige Brands (Gaviscon and Beano), Bayer (RestoraLAX and Alka-Seltzer), as well as Shoppers Drug Martís Life brand; each holding a value share of 5-10% in 2015. Bayer, previously holding brands such as Alka-Seltzer, more than doubled its share in digestive remedies due to its acquisition of Merckís consumer health business, including RestoraLAX, in 2014.

Full Report Details at
- http://www.fastmr.com/prod/1097843_digestive_remedies_canada.aspx?afid=301

Industry Prospects

Digestive remedies is predicted to record a static CAGR at constant 2015 prices over the forecast period, to reach C$421 million in 2020. Most of the drivers behind the growth in 2015 are likely to continue to direct the growth of the category, including demographic changes, the growing number of people with digestive problems and busy lifestyles.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Digestive Remedies industry in Canada with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Digestive Remedies industry in Canada, our research will save you time and money while empowering you to make informed, profitable decisions.

The Digestive Remedies in Canada market research report includes:

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Digestive Remedies in Italy
- Digestive Remedies in Belgium
- Digestive Remedies in the Netherlands
- Digestive Remedies in the United Arab Emirates
- Digestive Remedies in Finland

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »